首页> 外文会议>Universitas Ahmad Dahlan Public Health Conference >Qualitative Study: Leverage and Barrier Factors of Mass Drug Administration for Lymphatic Filariasis Elimination Program in Tangerang and Subang Regency
【24h】

Qualitative Study: Leverage and Barrier Factors of Mass Drug Administration for Lymphatic Filariasis Elimination Program in Tangerang and Subang Regency

机译:定性研究:唐先朗与亚阳摄政淋巴丝体消除方案的大规模药物管理局杠杆和屏障因素

获取原文

摘要

Tangerang and Subang Regency had implemented a national effort to eliminate lymphatic filariasis by five rounds of Mass Drug Administration (MDA) using diethylcarbamazine (DEC) and albendazole (ALB), pre-Transmission Assessment Survey, TAS-1 (Subang Regency); and TAS-2 (Tangerang Regency). The aim of this study is to analyze leverage and barrier factors of MDA lymphatic filariasis elimination program. The research was conducted by using qualitative approach through an in-depth interview from 84 informants to obtained information about the implementation of MDA for lymphatic filariasis elimination policy, resources and community empowerment in three-level health leading sector (Province, Regency, and District), and cross-sector collaboration. The sampling was done purposively and analyzed with thematic analysis. The leverage factors of implementation MDA for LF programs were local government's commitment and the existence of health volunteer as community empowerment. Barriers found in its implementation included motivation of health volunteer through incentives and training, inadequate information about MDA LF and a limited number of drug distributors to monitor adverse effects. Mass drug administration for lymphatic filariasis elimination programs should hold promotion strategies and surveillance model in Post MDA based on specific contextual factors to improve implementation outcomes.
机译:唐汉朗和亚阳丽晶已经实施了使用二乙基氨基吡嗪(DEC)和Albendazole(ALB),预传输评估调查,TAS-1(Subang Regency)通过五轮大规模药物管理局(MDA)消除淋巴丝虫病的国家努力;和TAS-2(Tangerang Regency)。本研究的目的是分析MDA淋巴丝体消除计划的杠杆和屏障因素。通过使用定性方法通过来自84名Informants的有关淋巴丝虫病的MDA的执行信息的信息进行了定性方法,以获得淋巴丝虫病的删除政策,资源和社区赋权在三级卫生领导部门(省,摄政和区)的信息和跨部门协作。采样是用主题分析进行用作分析的,分析。 LF计划实施MDA的杠杆因素是当地政府的承诺和作为社区赋权的健康志愿者的存在。在其实施中发现的障碍包括通过激励和培训的健康志愿者的动机,有关MDA LF的信息和有限数量的药物分销商来监测不利影响的信息。淋巴丝体的大规模药物申报淘汰计划应根据特定的背景因素持有邮政MDA促进策略和监测模型,以改善实施成果。

著录项

相似文献

  • 外文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号